Leptin in HIV associated vascular diseases

Project: Research project

Project Details

Description

PROJECT NARRATIVE Atherosclerosis-associated cardiovascular diseases are currently the leading cause of death in HIV patients under antiretroviral therapy. However, the molecular mechanisms predisposing HIV+ patients to atherosclerosis remain poorly defined and unstudied. The proposed study will combine the use of novel genetically engineered animal models with discarded human samples, cultured endothelial cells and pharmacological approaches to decipher the respective contribution of viral infection and antiretroviral therapy to the formation of atherosclerotic lesions.
StatusNot started

Funding

  • National Heart, Lung, and Blood Institute: $448,527.00
  • National Heart, Lung, and Blood Institute: $448,527.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.